Kiran Mazumdar Shaw is the chairperson and managing director of Biocon , the company which recently received US Food and Drug Administrator's approval for its anti cancer drug Trastuzumab
Wasserstrom discusses China's political evolution under Xi Jinping and tells Rahul Jacob he sees little reason to be hopeful
The disadvantage India has is that business-to-business (B2B) start-ups have not been able to scale, says Cisco Chairman John Chambers
Virendra Gupta says that about 63% of our readers are between 18 and 35 years old
He says the company is on top of property insurance and is proud of claim settlements
There are multiple introvert and extrovert events and actions that will help India remain a sought-after investment destination for the next few years
Interview with Sudhir Maheshwari, founder and managing partner, Synergy Capital
Interview with Seshagiri Rao, joint managing director and group chief financial officer at JSW Steel
Interview with Terry Peigh, managing director, Interpublic Group
Kazakhstan's national airline Air Astana is planning an IPO
Anderson's mission has been to make ideas that matter accessible
Interview with Sunil Mittal, Chairman, Bharti Enterprises
Interview with Bhushan Steel's promoter Neeraj Singal
Company expects third and fourth quarters to be more buoyant on increased leisure, corporate travel
LPs looking for fund managers with differential skill-sets
Another issue was the ability to attract and retain talent: Sudhanshu Vats
Executive vice-president of Siemens in India talks about the effect of GST on the industry and about the company's plans for India
Narayan talks to Business Standard about how things changed for TeamIndus when it moved to Bengaluru from Delhi and why his daughter is no longer impressed by his mugshot in a newspaper
When we first started DSGCP, we agreed to be opportunistic and refine the strategy once we were in the market: Deepak Shahdadpuri
Interview with Norton CEO Stuart Garner